| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 75.236 | 84.913 | 95.924 | 102.818 | 122.423 | 149.388 | 147.918 | 155.427 | 187.042 | 201.788 |
| Total Income - EUR | 75.280 | 84.913 | 95.924 | 102.849 | 122.435 | 149.913 | 147.964 | 156.078 | 187.674 | 202.372 |
| Total Expenses - EUR | 68.128 | 75.239 | 89.552 | 96.094 | 114.478 | 133.967 | 127.958 | 141.754 | 169.617 | 199.481 |
| Gross Profit/Loss - EUR | 7.152 | 9.674 | 6.372 | 6.755 | 7.957 | 15.946 | 20.006 | 14.324 | 18.057 | 2.891 |
| Net Profit/Loss - EUR | 5.974 | 8.825 | 5.413 | 5.727 | 6.733 | 14.755 | 18.710 | 12.763 | 16.181 | -3.180 |
| Employees | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Farmacon Sn S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.192 | 4.162 | 4.764 | 4.676 | 3.201 | 0 | 0 | 1.202 | 735 | 5.484 |
| Current Assets | 7.503 | 10.436 | 6.660 | 8.298 | 11.084 | 21.148 | 28.030 | 38.066 | 49.138 | 37.202 |
| Inventories | 5.742 | 9.032 | 5.234 | 6.710 | 9.405 | 18.081 | 20.851 | 31.685 | 42.462 | 30.956 |
| Receivables | 1.336 | 1.252 | 1.333 | 1.359 | 1.376 | 1.513 | 3.377 | 2.488 | 2.959 | 2.806 |
| Cash | 426 | 152 | 93 | 228 | 303 | 1.555 | 3.803 | 3.892 | 3.717 | 3.440 |
| Shareholders Funds | 7.952 | 10.783 | 7.338 | 7.617 | 8.586 | 16.573 | 20.488 | 25.204 | 35.243 | 23.825 |
| Social Capital | 1.937 | 1.917 | 1.885 | 1.850 | 1.814 | 1.780 | 1.740 | 1.746 | 1.740 | 1.731 |
| Debts | 3.743 | 3.814 | 4.086 | 5.357 | 5.700 | 4.576 | 7.542 | 14.064 | 14.630 | 18.860 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacon Sn S.r.l.